Past Scientific Advisory Committee Members

  • Dr. Neil Buckholtz

    Dr. Neil Buckholtz served as the Director of the Division of Neuroscience at the National Institute on Aging (NIA) at the National Institutes of Health. During his twenty-five year tenure at NIA, Dr. Buckholtz was responsible for developing and managing many signature extramural research programs including the Alzheimer’s Disease (AD) drug discovery and development,...

  • Dr. Gary Landreth

    Dr. Landreth is a Professor of Neurosciences and Neurology and the Director of the Alzheimer Research Laboratory at Case Western Reserve University, School of Medicine. Gary Landreth received his undergraduate degree in Chemistry and Biochemistry from the University of Kansas in 1972.  He then completed a Ph.D. in the Neuroscience Program at the University...

  • Dr. Andres Lozano

    Dr. Lozano is the RR Tasker Chair Dan Family Chairman of Neurosurgery at the University of Toronto and is a neurosurgeon at Toronto Western Hospital. He also holds a Tier I Canada Research Chair in Neuroscience. Andres Lozano was born in Sevilla, Spain and moved to Canada with his family at the age of...

  • Dr. Michael J. O’Neill

    Dr. O’Neill received a doctorate in pharmacology from University College in Galway, Ireland and later joined Eli Lilly & Co. where he worked for 24 years. He held a variety of roles, led several drug discovery efforts and managed a variety of teams at Lilly. From 2014-2018 he was the Head of the Molecular...

  • Dr. Philip Scheltens

    Dr. Philip Scheltens is Professor of Cognitive Neurology and the Director of the Alzheimer Center at the VU University Medical Center in Amsterdam. He is also the initiator and Vice President of Deltaplan Dementia Netherlands. In 2011 Dr. Scheltens was appointed scientific director at the Pearlstring Institute and elected a Member of the Royal...

  • Dr. Günter Höglinger

    Dr. Günter Höglinger is the Director of the Dept. of Neurology at Hannover Medical University since June 2019, and President of the German Parkinson Society since March 2019. Before that, he held the Chair for Translational Neurodegeneration at the German Center for Neurodegenerative Diseases (DNZE), Munich, and the Technical University of Munich (TUM). Dr....

  • Dr. Gene Johnson (Emeritus)

    Dr. Johnson is a Professor of Neurology at Washington University in St. Louis and also serves as the Chief Scientific Advisor at the Michael J. Fox Foundation. Gene Johnson received his undergraduate training in Pharmacy and a PhD in Medicinal Chemistry at the University of Maryland. He has been on the faculty at Washington...

  • Dr. Paul Schulz

    Dr. Schulz is a Professor of Neurology at the University of Texas and the director of the Memory Disorders and Dementia Clinic at the Mischer Neuroscience Institute in Houston. He received his combined BA-MD degrees from Boston University in 1984. He did a medical internship there, and moved to Baylor College of Medicine for...

  • Dr. Pim van Gool

    Professor, Dr. van Gool has over 25 years of experience, in medicine, research and science. Undergraduate training in basic neuroscience at the Netherlands Institute of Brain Research led Dr. van Gool to pursue a PhD on animal studies of brain aging which he completed in 1987. He continued his training in medicine and then...

  • Dr. Wai Haung Yu

    Dr. Yu is an Assistant Professor at the Taub Institute of Columbia University and serves on the scientific review boards for the Alzheimer’s Drug Discovery Foundation and the Veteran’s Administration. Wai Haung Yu, a Canadian-born scientist, received his PhD from the University of Toronto (Pharmacology) in 2001. While at the University of Toronto, he...

  • Dr. Holly B. Posner

    Dr. Holly B. Posner, MD, MS Epidemiology, has over 15 years of experience conducting clinical research evaluating potential therapeutic interventions for dementia, epilepsy and more recently, juvenile idiopathic arthritis. Aside from her work for pharmaceutical companies, she has also been involved in research to improve the assessment of outcome measures used to assess cognition...

  • Dr. Erik Roberson

    Dr. Roberson is Professor of Neurology and Neurobiology at the University of Alabama at Birmingham (UAB), where he directs the Center for Neurodegeneration and Experimental Therapeutics and the Alzheimer’s Disease Center. He received his A.B. with highest honors from Princeton University and then earned his M.D. and Ph.D in neuroscience at Baylor College of...

  • Dr. Caryl Sortwell

    Dr. Caryl Sortwell completed her undergraduate degree in biological psychology at the University of Illinois, Urbana and continued her training in Anatomy and Cell Biology at the University of Illinois, Chicago, receiving her PhD in 1994. Under the mentorship of Dr. John Sladek, Jr and Dr. Timothy Collier, Dr. Sortwell received postdoctoral training. It...

  • Dr. Linda Van Eldik

    Dr. Linda Van Eldik is the Director of the Sanders-Brown Center on Aging and Alzheimer’s Disease Center, Co-Director of the Kentucky Neuroscience Institute, and a Professor in the Department of Anatomy & Neurobiology at the University of Kentucky in the United States. She completed her undergraduate degree in biology at Calvin College in Michigan,...

  • Dr. Henrik Zetterberg

    Henrik Zetterberg is a Professor of Neurochemistry at the University of Gothenburg, Sweden, and University College London, UK, and a Clinical Chemist at Sahlgrenska University Hospital in Gothenburg. He is Head of the Department of Psychiatry and Neurochemistry at the University of Gothenburg and leads the UK DRI Fluid Biomarker Laboratory at UCL. His...